Blog
Designing The Appropriate Common Stock Retirement Portfolio: Stock Selection Options: Part 2
2019-07-25
Introduction This article is a refresh and an update of an article I originally posted in 2015. However, the principles I am presenting are timeless and worthy of being revisited. Moreover, I have updated the supporting examples to more precisely reflect our current market environment. In part 1 of this series I discussed two important […]
Beware the Valuations of The Dividend Kings Fortress Portfolio
2019-07-24
Research Articles, Uncategorized
One of the great benefits for subscribing to The Dividend Kings service are the carefully-selected portfolios presented in our portfolio tracker. However, I want to caution the subscriber that these portfolios should not be looked at as simply cut-and-paste investment options. Instead, I believe our subscribers should understand that these portfolios are suggested research candidates […]
Illinois Tool Works: An Exercise In Fair Value (ITW)
2019-07-18
Illinois Tool Works, Inc. manufactures industrial products and equipment. It operates through the following segments: Automotive OEM, Test & Measurement and Electronics, Food Equipment, Polymers & Fluids, Welding, Construction Products, and Specialty Products. The Automotive OEM segment produces components and fasteners for automotive-related applications. The Test & Measurement and Electronics segment manufactures equipment, consumables, and […]
Principles for Designing A Dividend Growth Portfolio for Retirement: Part 1
2019-07-17
Introduction This article is a refresh and an update of an article I originally posted in 2015. However, the principles I am presenting are timeless and worthy of being revisited. Moreover, I have updated the supporting examples to more precisely reflect our current market environment. Managing an investment portfolio is a very personal matter. Consequently, […]
Debunking the Growth Beats Value or Value Beats Growth Myths
2019-07-17
Introduction The Value Beats Growth Or Vice Versa Myths One of my greatest pet peeves as a long-time investment professional is the industries’ notion that stocks can be generally categorized into only two styles commonly referred to as growth investing or value investing. These overly-vague notions about investing in stocks can even be seen in […]
Subscriber Request Series: Celgene Corp (NAS:CELG) and Bristol Myers (NYS:BMY)
2019-07-11
FAST Graphs Analyze Out Loud Celgene Corp $CELG: Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include REVLIMID, POMALYST, IMNOVID, OTEZLA, ABRAXANE, and VIDAZA. The company was founded by David Stirling and […]